Green, Colin; Picot, Joanna; Loveman, Emma; Takeda, Andrea - In: PharmacoEconomics 23 (2005) 12, pp. 1271-1282
Objective: To estimate the cost effectiveness (from the UK NHS and personal social services perspective) of the cholinesterase inhibitors donepezil, rivastigmine and galantamine compared with usual care in the treatment of mild to moderately severe Alzheimer's disease. Patients had a mean age of...